Given that SP has emerged as an index of host inflammatory response, sources of infection, and mortality in patients with sepsis, our study could facilitate the development of novel adjuvant treatment for sepsis in clinic, targeting the SP-NK1R cascade. The gene discussed is TACR1; the disease is Sepsis.